Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation

Transplantation

Volumn 73, Issue 8, 2002, Pages 1280-1285

  Ottinger, Hellmut D ^a   Rebmann, Vera ^a   Pfeiffer, Kerstin A ^a   Beelen, Dietrich W ^a   Kremens, Bernhard ^a   Runde, Volker ^a   Schaefer, Ulrich W ^a   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; KAPLAN MEIER METHOD; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037181633     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200204270-00016     Document Type: Article

References (28)

1. Presensitization detected by sensitive crossmatch tests
2. Variations on the lymphocytotoxicity test
3. Importance of methodology in the flow cytometric crossmatch: A multicenter study
4. Comparison of XM results obtained by ELISA, flow cytometry, and conventional methodologies
5. Comparison between enzyme-linked immuno-sorbent assay and cytotoxic cross match procedures for detecting IgG anti-donor antibodies
6. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation
7. Flow cytometric detection of HLA antibodies using a spectrum of microbeads
8. Significance of the positive crossmatch test in kidney transplantation
9. Kidney transplantability across a positive crossmatch. Crossmatch assays and distribution of B lymphocytes in donor tissues
10. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching
11. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and crossmatching
12. Significance of preformed anti-donor antibodies in liver transplantation
13. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation
14. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry
15. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection
16. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma
17. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: Final results and long-term follow-up of an open-label prospective randomized trial
18. Clinical results and the Essen concept of TBI
19. Six weeks of continuous intravenous cyclosporine and short course methotrexate as prophylaxis of graft-versus-host disease after allogeneic bone marrow transplantation
20. Non-parametric estimation from incomplete observations
21. Regression models and life tables
22. Incidence of primary graft failure (PGF) and autochthonous hematopoietic reconstitution (AHR) in recipients of allogeneic stem cell transplants
23. Effect of HLA incompatibility on graft-versus-host disease, relapse and survival after bone marrow transplantation for patients with leukemia or lymphoma
24. Bone marrow transplantation from partially HLA mismatched related donors in adults with leukaemia: The experience at the University Hospital of Essen, Germany
25. The Essen concept of donor selection for allotransplantation of hematopoietic stem cells: A retrospective single center study enrolling 412 patients
26. B peripheral lymphocytes express more HLA antigens than peripheral T lymphocytes
27. Successful transplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto protein A
28. Progress of unrelated bone marrow donor search at the University Hospital of Essen (1991-1994)